Luye Pharma's Weekly Rivastigmine Patch Approved in Japan for Alzheimer's
CompanyDrug

Luye Pharma’s Weekly Rivastigmine Patch Approved in Japan for Alzheimer’s

BeiGene's Tevimbra Recommended for EU Approval in Small Cell Lung Cancer
CompanyDrug

BeiGene’s Tevimbra Recommended for EU Approval in Small Cell Lung Cancer

Otsuka Files FDA Application for Sibeprenlimab in IgAN Treatment
CompanyDrug

Otsuka Files FDA Application for Sibeprenlimab in IgAN Treatment

Basecare Medical Reports 44% Revenue Growth in 2024 IVF Sector
Company

Basecare Medical Reports 44% Revenue Growth in 2024 IVF Sector

UCB's Rystiggo Approved in China for Generalized Myasthenia Gravis
CompanyDrug

UCB’s Rystiggo Approved in China for Generalized Myasthenia Gravis

Renji Hospital Raffles Medical Group Medical Tourism
DealsHospital

Renji Hospital Partners with Raffles Medical Group to Boost Shanghai’s Medical Tourism

AstraZeneca and Daiichi Sankyo Initiate DESTINY-Gastric05 Study for Enhertu in Metastatic Gastric Cancer
CompanyDrug

AstraZeneca and Daiichi Sankyo Initiate DESTINY-Gastric05 Study for Enhertu in Metastatic Gastric Cancer

China Proposes New Measures to Optimize High-End Medical Device Regulation
Medical DevicePolicy / Regulatory

China Proposes New Measures to Optimize High-End Medical Device Regulation

GE Healthcare Takes Full Ownership of Japan's Nihon Medi-Physics
CompanyDeals

GE Healthcare Takes Full Ownership of Japan’s Nihon Medi-Physics

Hengrui Pharmaceuticals' Ivarmacitinib Approved for Rheumatoid Arthritis in China
CompanyDrug

Hengrui Pharmaceuticals’ Ivarmacitinib Approved for Rheumatoid Arthritis in China

Chinese Firms Nanjing F&S and Hunan Huize Form Alliance for Full-Process Pharma Services
CompanyDeals

Chinese Firms Nanjing F&S and Hunan Huize Form Alliance for Full-Process Pharma Services

Huapont Life Sciences Gains NMPA Approval for Generic Daivobet
CompanyDrug

Huapont Life Sciences Gains NMPA Approval for Generic Daivobet